Link of Audio Recording of Investor/Analysts Conference Call
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs and Pharmaceuticals has disclosed that an investor/analyst conference call was held on May 18, 2026 at 12:00 PM IST to discuss un-audited Q4 FY 2026 and audited FY 2026 financial results. The company has shared a link to the audio recording of this call as per SEBI Regulation 30 and Part A of Schedule III requirements. A transcript of the call will be uploaded to the company's investor relations website at a later date. This is a routine regulatory compliance filing informing stakeholders about the availability of the earnings call recording.
This is an informational filing providing access to earnings call recordings. The actual impact on the stock will depend on the content discussed during the call, including any guidance or commentary on financial performance. Investors should listen to the recording or await the transcript for substantive details.